DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
LB80380
2
Small molecule
Investigational
Unknown
Unknown
Kidney Diseases; Hepatitis B, Chronic
DNA disrupting agent
LB80380
×
Maximum Phase:
2
First Approval:
None
UNII:
S9I9P4J8IU
Molecule Type:
Small molecule
Molecular Formula:
C22H34N5O8P
Molecular Weight:
527.52
AlogP:
3.24
PSA:
166.98
HBD:
1.0
HBA:
#RotB:
11.0
Source:
INCB040093
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
INCB040093
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SEPRANOLONE
2
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Unknown
SEPRANOLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
3P8Z6V53MU
Molecule Type:
Small molecule
Molecular Formula:
C21H34O2
Molecular Weight:
318.5
AlogP:
4.6
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BLARCAMESINE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Parkinson Disease; Rett Syndrome
Unknown
BLARCAMESINE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
1M49V1PBPL
Molecule Type:
Small molecule
Molecular Formula:
C19H24ClNO
Molecular Weight:
317.86
AlogP:
3.53
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MCS-110
2
Antibody
Investigational
Unknown
Unknown
Melanoma; Breast Neoplasms; Stomach Neoplasms
Macrophage colony-stimulating factor 1 inhibitor
MCS-110
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AL-78898A
2
Unknown
Investigational
Unknown
Unknown
Macular Degeneration
Complement C3 inhibitor
AL-78898A
×
Maximum Phase:
2
First Approval:
None
UNII:
T3B2AIZ4BF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARAMCHOL
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Fatty Liver; Gallstones; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease
Unknown
ARAMCHOL
×
Maximum Phase:
2
First Approval:
None
UNII:
QE1Q24M65Y
Molecule Type:
Small molecule
Molecular Formula:
C44H79NO5
Molecular Weight:
702.12
AlogP:
10.61
PSA:
106.86
HBD:
4.0
HBA:
#RotB:
23.0
Source:
TILSOTOLIMOD
2
Unknown
Investigational
Unknown
Unknown
Melanoma; Neoplasms
Toll-like receptor 9 agonist
TILSOTOLIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
G287IC9MH3
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAMOSIRAN
2
Oligonucleotide
Investigational
Unknown
Unknown
Unknown
Beta-2 adrenergic receptor mRNA RNAi inhibitor
BAMOSIRAN
×
Maximum Phase:
2
First Approval:
None
UNII:
C8Q2RMU41O
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEZULCITINIB
2
Small molecule
Investigational
Unknown
Unknown
Acute Lung Injury; Severe Acute Respiratory Syndrome
Unknown
NEZULCITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C30H37N7O2
Molecular Weight:
527.67
AlogP:
3.8
PSA:
104.38
HBD:
3.0
HBA:
#RotB:
6.0
Source:
GLYCERYL TRIOLEATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GLYCERYL TRIOLEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
O05EC62663
Molecule Type:
Small molecule
Molecular Formula:
C57H104O6
Molecular Weight:
885.45
AlogP:
18.1
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
50.0
Source:
POLYSTYRENE SULFONATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
POLYSTYRENE SULFONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELEPRESSIN
2
Protein
Investigational
Unknown
Unknown
Shock, Septic
Vasopressin V1a receptor agonist
SELEPRESSIN
×
Maximum Phase:
2
First Approval:
None
UNII:
8P2T76M0SJ
Molecule Type:
Protein
Molecular Formula:
C46H73N13O11S2
Molecular Weight:
1048.3
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SPA
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SPA
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPETIRIMOD
2
Small molecule
Investigational
Unknown
Unknown
Papillomavirus Infections
Unknown
EPETIRIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
9P5MH9F521
Molecule Type:
Small molecule
Molecular Formula:
C13H15N5
Molecular Weight:
241.3
AlogP:
2.22
PSA:
69.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
INDANTADOL
2
Small molecule
Investigational
Unknown
Unknown
Cough; Diabetic Neuropathies; Neuralgia; Pain
Glutamate [NMDA] receptor antagonist
INDANTADOL
×
Maximum Phase:
2
First Approval:
None
UNII:
Z3867B9SQP
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DONANEMAB
2
Antibody
Investigational
Unknown
Unknown
Alzheimer Disease
Beta amyloid A4 protein disrupting agent
DONANEMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
1ADB65P1KK
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DARIGABAT
2
Small molecule
Investigational
Unknown
Unknown
Panic Disorder; Anxiety Disorders; Epilepsy, Reflex; Low Back Pain; Seizures
GABA-A receptor; anion channel agonist
DARIGABAT
×
Maximum Phase:
2
First Approval:
None
UNII:
O9BP19HZ3Q
Molecule Type:
Small molecule
Molecular Formula:
C22H21FN4O3S
Molecular Weight:
440.5
AlogP:
4.12
PSA:
86.97
HBD:
0.0
HBA:
#RotB:
6.0
Source:
FLUZOPARIB
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Neoplasms; Small Cell Lung Carcinoma; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Nasopharyngeal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
FLUZOPARIB
×
Maximum Phase:
2
First Approval:
None
UNII:
TWF0ML1CK8
Molecule Type:
Small molecule
Molecular Formula:
C22H16F4N6O2
Molecular Weight:
472.4
AlogP:
2.92
PSA:
96.77
HBD:
1.0
HBA:
#RotB:
3.0
Source:
18F-FSPG
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
18F-FSPG
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GRAPIPRANT
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Osteoarthritis
Prostanoid EP4 receptor antagonist
GRAPIPRANT
×
Maximum Phase:
2
First Approval:
None
UNII:
J9F5ZPH7NB
Molecule Type:
Small molecule
Molecular Formula:
C26H29N5O3S
Molecular Weight:
491.62
AlogP:
4.14
PSA:
105.98
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CARBOXYMETHYLCELLULOSE CALCIUM
2
Unknown
Investigational
Unknown
Unknown
Conjunctivitis, Viral
Unknown
CARBOXYMETHYLCELLULOSE CALCIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
UTY7PDF93L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALDAFERMIN
2
Protein
Investigational
Unknown
Unknown
Constipation; Kidney Diseases; Liver Diseases; Cholangitis, Sclerosing; Diabetes Mellitus; Liver Cirrhosis, Biliary; Non-alcoholic Fatty Liver Disease
Unknown
ALDAFERMIN
×
Maximum Phase:
2
First Approval:
None
UNII:
IK9NYN31ZM
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEMPOL
2
Small molecule
Investigational
Unknown
Unknown
Anus Neoplasms; Cardiovascular Diseases; Alopecia; Glioblastoma; Prostatic Neoplasms, Castration-Resistant; Severe Acute Respiratory Syndrome
Unknown
TEMPOL
×
Maximum Phase:
2
First Approval:
None
UNII:
U78ZX2F65X
Molecule Type:
Small molecule
Molecular Formula:
C9H18NO2
Molecular Weight:
172.25
AlogP:
1.35
PSA:
43.37
HBD:
1.0
HBA:
#RotB:
0.0
Source:
GUSACITINIB
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Dermatitis; Dermatitis, Atopic
Janus Kinase (JAK) inhibitor
GUSACITINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
4801QYW816
Molecule Type:
Small molecule
Molecular Formula:
C24H28N8O2
Molecular Weight:
460.54
AlogP:
2.55
PSA:
134.06
HBD:
3.0
HBA:
#RotB:
5.0
Source:
LURTOTECAN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Small Cell Lung Carcinoma
Unknown
LURTOTECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
4J1L80T08I
Molecule Type:
Small molecule
Molecular Formula:
C28H30N4O6
Molecular Weight:
518.57
AlogP:
1.6
PSA:
106.36
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AKN-028
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
AKN-028
×
Maximum Phase:
2
First Approval:
None
UNII:
Y66IS3CS0R
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AXOMADOL
2
Small molecule
Investigational
Unknown
Unknown
Chronic Pain; Pain; Low Back Pain
Delta opioid receptor agonist
AXOMADOL
×
Maximum Phase:
2
First Approval:
None
UNII:
9J92U4CVS0
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO3
Molecular Weight:
279.38
AlogP:
1.61
PSA:
52.93
HBD:
2.0
HBA:
#RotB:
4.0
Source:
RHEUM PALMATUM ROOT
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
RHEUM PALMATUM ROOT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DESLORELIN
2
Protein
Investigational
Unknown
Unknown
Growth Disorders; Hereditary Breast and Ovarian Cancer Syndrome; Puberty, Precocious
Unknown
DESLORELIN
×
Maximum Phase:
2
First Approval:
None
UNII:
TKG3I66TVE
Molecule Type:
Protein
Molecular Formula:
C64H83N17O12
Molecular Weight:
1282.47
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GTI-2040
2
Unknown
Investigational
Unknown
Unknown
Neoplasms; Breast Neoplasms, Male; Leukemia, Myeloid, Acute; Prostatic Neoplasms, Castration-Resistant
Ribonucleotide reductase small subunit mRNA antisense inhibitor
GTI-2040
×
Maximum Phase:
2
First Approval:
None
UNII:
5WY0FWR2CF
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFATUTAZONE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Peroxisome proliferator-activated receptor gamma agonist
EFATUTAZONE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
76B44WEA8O
Molecule Type:
Small molecule
Molecular Formula:
C27H28Cl2N4O4S
Molecular Weight:
575.52
AlogP:
5.04
PSA:
108.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
T-817 MALEATE
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Alzheimer Disease; Cognitive Dysfunction
Unknown
T-817 MALEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
0LB9F7I5P3
Molecule Type:
Small molecule
Molecular Formula:
C20H25NO6S
Molecular Weight:
407.49
AlogP:
2.53
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CARBASALATE CALCIUM
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CARBASALATE CALCIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OPIGOLIX
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Endometriosis
Gonadotropin-releasing hormone receptor antagonist
OPIGOLIX
×
Maximum Phase:
2
First Approval:
None
UNII:
VQ6CK0CITA
Molecule Type:
Small molecule
Molecular Formula:
C25H19F3N4O5S
Molecular Weight:
544.51
AlogP:
3.56
PSA:
148.45
HBD:
5.0
HBA:
#RotB:
7.0
Source:
1
2
…
163
164
165
166
167
168
169
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA